Share

April 14, 2020; 94 (15 Supplement) Sunday, April 26

Long-term Safety and Efficacy of Patisiran in Patients with hATTR Amyloidosis: Global OLE Study (730)

Michael Polydefkis, Alejandra González-Duarte, Teresa Coelho, Jonas Wixner, Arnt Kristen, Hartmut Schmidt, John L. Berk, Erhan Berber, Marianne Sweetser, Matthew White, Jing Jing Wang, David Adams
First published April 14, 2020,
Citation
Permissions

Make Comment

See Comments

Downloads
0

Share

Article Information

vol. 94 no. 15 Supplement 730
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • First Published April 14, 2020.
Copyright & Usage: 
© 2020

Author Disclosures

    1. Michael Polydefkis1,
    2. Alejandra González-Duarte2,
    3. Teresa Coelho3,
    4. Jonas Wixner4,
    5. Arnt Kristen5,
    6. Hartmut Schmidt6,
    7. John L. Berk7,
    8. Erhan Berber8,
    9. Marianne Sweetser8,
    10. Matthew White8,
    11. Jing Jing Wang8 and
    12. David Adams9
  1. Michael Polydefkis1,
  2. Alejandra González-Duarte2,
  3. Teresa Coelho3,
  4. Jonas Wixner4,
  5. Arnt Kristen5,
  6. Hartmut Schmidt6,
  7. John L. Berk7,
  8. Erhan Berber8,
  9. Marianne Sweetser8,
  10. Matthew White8,
  11. Jing Jing Wang8 and
  12. David Adams9
  1. 1Johns Hopkins University
  2. 2Instituto Nacional de Ciencias Médicas y Nutrición
  3. 3Hospital de Santo António
  4. 4Department of Public Health and Clinical Medicine, Umeå University
  5. 5Heidelberg University Hospital
  6. 6University Hospital Muenster
  7. 7Amyloid Treatment and Research Program, Boston University
  8. 8Alnylam Pharmaceuticals
  9. 9National Reference Center for FAP (NNERF)/APHP/INSERM U 1195/CHU Bicêtre

Article usage

Article usage: April 2020 to April 2023

AbstractFullPdfSource
Apr 20201100Highwire
May 20203100Highwire
Jun 20201000Highwire
Jul 20201000Highwire
Aug 20201900Highwire
Sep 2020400Highwire
Oct 20202400Highwire
Nov 20203100Highwire
Dec 20202700Highwire
Jan 20212400Highwire
Feb 2021900Highwire
Mar 2021800Highwire
Apr 2021800Highwire
May 2021800Highwire
Jun 2021700Highwire
Jul 2021500Highwire
Aug 20211100Highwire
Sep 20211400Highwire
Oct 2021500Highwire
Nov 20211400Highwire
Dec 20211000Highwire
Jan 2022600Highwire
Feb 20221500Highwire
Mar 20221100Highwire
Apr 2022500Highwire
May 20221900Highwire
Jun 20221600Highwire
Jul 2022900Highwire
Aug 20221300Highwire
Sep 2022800Highwire
Oct 2022700Highwire
Nov 2022800Highwire
Dec 2022700Highwire
Jan 20231000Highwire
Feb 2023200Highwire
Mar 2023800Highwire
Apr 2023600Highwire

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Alert Me